MGTX - メイラGTxホ―ルディングス (MeiraGTx Holdings plc) メイラGTxホ―ルディングス

 MGTXのチャート


 MGTXの企業情報

symbol MGTx
会社名 MeiraGTx Holdings PLC (メイラGTxホ―ルディングス)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 メイラ・ジー・ティー・エックス・ホールディングス(MeiraGTx Holdings plc)は臨床段階の遺伝子治療事業に従事する会社である。同社は、一連の遺伝性疾患及び後天性疾患の遺伝子治療技術を開発する。同社は主に、遺伝性失明症、口腔乾燥症、頭頸部癌の放射線治療、及び甲状腺機能低下症(ALS)などの神経変性疾患を含む眼疾患の治療法開発に従事する。また、小分子の使用により遺伝子治療製品の候補を有効または無効にするための変革技術を開発する。同社は、遺伝性網膜疾患、重度の形態の口腔乾燥症及び神経変性疾患を含む、満たされていない医療ニーズの3つの分野に集中する。同社の製品には、AAV-CNGB3 AAV-CNGA3 AAV-RPGR AAV-RPE65 A006 AAV-AQP1及びAAV-UPF1を含む。   メイラGTxホ―ルディングスは米国のバイオ医薬品企業。目、唾液腺および中枢神経系の疾患に対する遺伝子治療法の開発に焦点を当て事業を行う。進行中の臨床プログラムのほか、前臨床および臨床段階の研究プログラムの幅広いパイプラインを保有し、遺伝子治療薬の製造を手掛ける。また、形質転換型の遺伝子制御技術を提供する。本社所在地はニューヨーク。   MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.
本社所在地 430 East 29th Street 10th Floor New York NY 10016 USA
代表者氏名
代表者役職名
電話番号
設立年月日 43221
市場名 NASDAQ National Market System
ipoyear 2018年
従業員数 59人
url www.meiragtx.com
nasdaq_url https://www.nasdaq.com/symbol/mgtx
adr_tso
EBITDA EBITDA(百万ドル) -59.48334
終値(lastsale) 13.255
時価総額(marketcap) 360325669.66
時価総額 時価総額(百万ドル) 363.14670
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 261.13565
当期純利益 当期純利益(百万ドル) -65.98993
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 MeiraGTx Holdings PLC revenues was not reported. Net loss applicable to common stockholders increased from $14.1M to $48.2M. Higher net loss reflects General and administrative increase from $2.1M to $17.7M (expense) Stock-based Compensation in SGA increase from $131K to $10.8M (expense) Research and development increase from $4.8M to $12.8M (expense).

 MGTXのテクニカル分析


 MGTXのニュース

   The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief  2019/07/03 11:31:07 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 2) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) ArQule, Inc. (NASDAQ: ARQL ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Coherus Biosciences Inc (NASDAQ: CHRS ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 2) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Atreca Inc (NASDAQ: BCEL )(IPOed June 20) Biopharmx Corp (NYSE: BPMX ) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Nuvectra Corp (NASDAQ: NVTR ) Personalis Inc (NASDAQ: PSNL ) (IPOed June 20) Prevail Therapeutics Inc (NASDAQ: PRVL ) (IPOed June 20) Sienna Biopharmaceuticals Inc (NASDAQ: SNNA ) Surface Oncology Inc (NASDAQ: SURF ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) TrovaGene Inc (NASDAQ: TROV ) See Also: Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates Stocks In Focus Roche's Flu Medication Found Effective And Safe In Children Roche Holdings AG Basel …
   The Daily Biotech Pulse: Celyad To Advance Leukemia Drug To Clinical Trial, Positive Data For Teva's Migraine Drug  2019/07/02 11:29:04 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 1) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Axsome Therapeutics Inc (NASDAQ: AXSM ) (the company's stock has been added to Russell 3000 and Russell 2000 Indexes) Coherus Biosciences Inc (NASDAQ: CHRS )(announced that it has produced over 400,000 Udenyca pre-filled syringes to date) Fate Therapeutics Inc (NASDAQ: FATE ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) Misonix, Inc. (NASDAQ: MSON ) (the company's stock has been added to Russell 3000 and Russell 2000 Indexes) Morphic Holding Inc (NASDAQ: MORF )(IPOed June 27) Odonate Therapeutics Inc (NASDAQ: ODT ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) ResMed Inc. (NYSE: RMD ) Tricida Inc (NASDAQ: TCDA ) Vapotherm Inc (NYSE: VAPO ) Zai Lab Ltd (NASDAQ: ZLAB ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 1) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Artelo Biosciences Inc (NASDAQ: ARTL ) CELLECT …
   3 Gene Therapy Stocks For A Biotech Portfolio  2019/05/20 16:53:25 Seeking Alpha
   The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering  2019/05/17 12:03:47 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on May 16) Adverum Biotechnologies Inc (NASDAQ: ADVM )(announced lifting of FDA's partial clinical hold on the second cohort of Phase 1 study of its wet age-related macular degeneration drug) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Fate Therapeutics Inc (NASDAQ: FATE ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Masimo Corporation (NASDAQ: MASI )(received FDA nod for Radius PPG, a tetherless sensor solution) MediciNova, Inc. (NASDAQ: MNOV ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) TransMedics Group Inc (NASDAQ: TMDX ) Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 16) Auris Medical Holding Ltd (NASDAQ: EARS ) CELLECT BIOTECH/S ADR (NASDAQ: APOP )(announced exploration of strategic alternatives) Enochian Biosciences Inc (NASDAQ: ENOB ) NGM Biopharmaceuticals Inc (NASDAQ: NGM ) Nuvectra Corp (NASDAQ: NVTR )(announced departure of COO and CFO) Precision Therapeutics Inc (NASDAQ: AIPT )(reacted to its first-quarter results) Sellas Life Sciences Group Inc (NASDAQ: SLS ) (reacted to its first-quarter results) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) Tonix …
   The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenics  2019/05/16 11:40:02 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 15) Applied Therapeutics Inc (NASDAQ: APLT ) (debuted on Tuesday) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Avedro Inc (NASDAQ: AVDR ) Axsome Therapeutics Inc (NASDAQ: AXSM ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) Shockwave Medical Inc (NASDAQ: SWAV ) Silk Road Medical Inc (NASDAQ: SILK ) Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 15) Amneal Pharmaceuticals Inc (NYSE: AMRX ) Auris Medical Holding Ltd (NASDAQ: EARS ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI )(reacted to its third-quarter results) ENDRA Life Sciences Inc (NASDAQ: NDRA )(reacted to its first-quarter results) ImmunoGen, Inc. (NASDAQ: IMGN )(FDA required a new Phase 3 study to be conducted for its ovarian cancer drug) Nuvectra Corp (NASDAQ: NVTR ) Outlook Therapeutics Inc (NASDAQ: OTLK )(reacted to its second quarter results) Teva Pharmaceutical Industries Ltd (NYSE: TEVA ) United Therapeutics Corporation (NASDAQ: UTHR ) Stock In Focus Roche Gets FDA Nod For Leukemia Drug, Reports Positive Results For Solid Tumor Drug Roche Holdings AG Basel ADR (OTC: RHHBY ) said the FDA approved Venclexta in combination with Gazyva for treating people with previously untreated chronic lymphocytic leukemia, or CLL, or small lymphocytic lymphoma, or SLL.

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 メイラGTxホ―ルディングス MGTX MeiraGTx Holdings plc)

 twitter  (公式ツイッターやCEOツイッターなど)